Further exploration in tumor immune microenvironment revealed that the abundance of TIL increased, the expression of negative co-stimulatory molecules (PD-1/Lag-3/Tim-3) decreased, and the secretion of pro-inflammation cytokines (IFN-γ and TNF-α) elevated after Olaparib administration [118]. The gene discussed is TNF; the disease is neoplasm.